13 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
, reduced disclosure obligations regarding executive compensation in our periodic reports and exemptions from the requirements of holding a nonbinding … advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We could be an emerging growth
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
BUSINESS
MANAGEMENT
EXECUTIVE COMPENSATION
CERTAIN RELATIONSHIPS AND RELATED PARTY … ,” and “say on golden parachute” non-binding advisory vote requirements; and
we can provide reduced disclosures about our executive compensation arrangements
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
BUSINESS
MANAGEMENT
EXECUTIVE COMPENSATION
CERTAIN RELATIONSHIPS … requirements; and
we can provide reduced disclosures about our executive compensation arrangements.
We currently intend to take advantage of each
S-1
EX-99.3
80hhqug mqc3m49jpx
29 Jun 23
IPO registration
4:39pm
S-1
j9e34xdhkurawsp w0
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-99.3
xd1uuncg
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
i9w8i84
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
a1pzx66y5ozhxw
2 May 23
Draft registration statement (amended)
12:00am
DRS
ef8q9er
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next